MyFinsight
Home
Blog
About
Contact
Download
Download image
Net revenues
$171,171K
Interest income
$2,400K
Accounts payable and
accrued liabilities
$9,603K
Share-based compensation
expense
$9,274K
Depreciation of property,
plant, and equipment
$8,078K
Income tax refunds,
deposits, and payable, net
-$7,742K
Net income
$6,420K
Amortization of intangible
assets
$6,270K
Inventories
-$6,248K
Canceled cashflow
$167,151K
Operating lease
right-of-use asset...
$2,144K
Amortization of discounts,
premiums, and debt...
$761K
Loss on disposal of
assets
-$4K
Net cash provided by
operating activities
$47,840K
Canceled cashflow
$8,704K
Other segment items
$55,011K
Payroll expense
$50,618K
Depreciation and
amortization expense
$14,348K
Materials and supplies
$12,741K
Consulting and outside
services expense
$10,362K
Stock-based compensation
expense
$9,274K
Interest expense
$6,553K
Income tax provision
$3,632K
Advertising and promotional
expense
$3,060K
Clinical trials expense
$1,552K
Net increase in
cash, cash...
$762K
Canceled cashflow
$47,078K
Accounts receivable, net
$4,547K
Prepaid expenses and
other assets
$2,326K
Operating lease
liabilities
-$1,415K
(gain) loss on interest
rate swaps and...
$416K
Maturity of investments
$15,502K
Deposits and other assets
-$67K
Net cash used in
financing activities
-$30,207K
Net cash (used in)
provided by investing...
-$16,733K
Effect of exchange rate
changes on cash
-$138K
Canceled cashflow
$15,569K
Purchase of treasury
stock
$29,492K
Proceeds from equity
plans, net of...
$686K
Principal payments on
long-term debt
$29K
Purchase of investments
$22,795K
Purchases and
construction of property,...
$9,507K
Back
Back
Cash Flow
source: myfinsight.com
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)